Abstract
Background
Juvenile myelomonocytic leukemia (JMML) is a rare childhood hematopoietic disorder typically presenting with hepatosplenomegaly, lymphadenopathy, pallor, fever, and cutaneous findings. The authors report the first case, to our knowledge, of JMML presenting in a pediatric patient with a subdural hematoma.
Case description
A 7-month old male with recurrent respiratory infections and a low-grade fever presented with a full fontanelle and an increasing head circumference and was found to have chronic bilateral subdural collections. Abusive head trauma, infectious, and coagulopathy workups were unremarkable, and the patient underwent bilateral burr holes for evacuation of the subdural collections. The postoperative course was complicated by the development of thrombocytopenia, anemia, and an acute subdural hemorrhage which required evacuation. Cytologic analysis of the subdural fluid demonstrated atypical cells, which prompted flow cytometric analysis, a bone marrow biopsy, and ultimately a diagnosis of JMML. Following chemotherapy, the patient’s counts improved, and he subsequently underwent a hematopoietic stem cell transplant.
Conclusion
Subdural collections may rarely represent the first presenting sign of hematologic malignancies. In patients with a history of recurrent infections and a negative workup for abusive head trauma, clinicians should include neoplastic etiologies in the differential for chronic subdural collections and have a low threshold for fluid analysis.
Similar content being viewed by others
References
Abdulhamid MM, Li YM, Hall WA (2011) Spontaneous acute subdural hematoma as the initial manifestation of chronic myeloid leukemia. J Neuro-Oncol 101(3):513–516. https://doi.org/10.1007/s11060-010-0278-6
Basmaci M, Hasturk AE (2012) Chronic subdural hematoma in a child with acute myeloid leukemia after leukocytosis. Indian J Crit Care Med 16(4):222–224. https://doi.org/10.4103/0972-5229.106508
Board, P. D. Q. P. T. E (2002) Childhood acute myeloid leukemia/other myeloid malignancies treatment (PDQ®): health professional version. In: PDQ Cancer Information Summaries. National Cancer Institute (US), Bethesda
Bromberg JE, Vandertop WP, Jansen GH (1998) Recurrent subdural haematoma as the primary and sole manifestation of chronic lymphocytic leukaemia. Br J Neurosurg 12(4):373–376. https://doi.org/10.1080/02688699844934
Chan RJ, Cooper T, Kratz CP, Weiss B, Loh ML (2009) Juvenile myelomonocytic leukemia: a report from the 2nd International JMML Symposium. Leuk Res 33(3):355–362. https://doi.org/10.1016/j.leukres.2008.08.022
Choudhary AK, Servaes S, Slovis TL, Palusci VJ, Hedlund GL, Narang SK, Moreno JA, Dias MS, Christian CW, Nelson MD Jr, Silvera VM, Palasis S, Raissaki M, Rossi A, Offiah AC (2018) Consensus statement on abusive head trauma in infants and young children. Pediatr Radiol 48(8):1048–1065. https://doi.org/10.1007/s00247-018-4149-1
Comănescu A, Roşca E, Bota M, Ninulescu G (2008) Chronic subdural hematoma in a patient with acute myeloid leukemia and dural metastatic infiltration. Romanian J Morphol Embryol 49(2):259–262
Cseh A, Niemeyer CM, Yoshimi A, Dworzak M, Hasle H, van den Heuvel-Eibrink MM, Locatelli F, Masetti R, Schmugge M, Groß-Wieltsch U, Candás A, Kulozik AE, Olcay L, Suttorp M, Furlan I, Strahm B, Flotho C (2015) Bridging to transplant with azacitidine in juvenile myelomonocytic leukemia: a retrospective analysis of the EWOG-MDS study group. Blood 125(14):2311–2313. https://doi.org/10.1182/blood-2015-01-619734
Flotho C (2019) Gene mutations do not operate in a vacuum: the increasing importance of epigenetics in juvenile myelomonocytic leukemia. Epigenetics 14(3):236–244. https://doi.org/10.1080/15592294.2019.1583039
Hamdy N, Bokhary H, Elsayed A, Hozayn W, Soliman S, Salem S, Alsheshtawi K, Abdalla A, Hafez H, Hammad M (2020) RAS pathway mutation patterns in patients with juvenile myelomonocytic leukemia: a developing country single-center experience. Clin Lymphoma Myeloma Leuk 20(7):e368–e374. https://doi.org/10.1016/j.clml.2020.02.003
Iversen PO, Rodwell RL, Pitcher L, Taylor KM, Lopez AF (1996) Inhibition of proliferation and induction of apoptosis in juvenile myelomonocytic leukemic cells by the granulocyte-macrophage colony-stimulating factor analogue E21R. Blood 88(7):2634–2639
Jourdan E, Dombret H, Glaisner S, Micléa JM, Castaigne S, Degos L (1995) Unexpected high incidence of intracranial subdural haematoma during intensive chemotherapy for acute myeloid leukaemia with a monoblastic component. Br J Haematol 89(3):527–530. https://doi.org/10.1111/j.1365-2141.1995.tb08358.x
Kitano A, Yamamoto K, Nagao T, Yoshida M, Kurosu T, Arai A, Miki T, Murakami N, Miura O (2005) Successful treatment with drainage of hematoma and chemotherapy in a case of Burkitt leukemia presenting with subdural hematoma. Rinsho Ketsueki 46(4):278–280
Koike K, Matsuda K (2008) Recent advances in the pathogenesis and management of juvenile myelomonocytic leukaemia. Br J Haematol 141(5):567–575. https://doi.org/10.1111/j.1365-2141.2008.07104.x
Kratz CP, Niemeyer CM (2005) Juvenile myelomonocytic leukemia. Hematology 10(Suppl 1):100–103. https://doi.org/10.1080/10245330512331390078
Lasho T, Patnaik MM (2020) Juvenile myelomonocytic leukemia - a bona fide RASopathy syndrome. Best Pract Res Clin Haematol 33(2):101171. https://doi.org/10.1016/j.beha.2020.101171
Lin CH, Hung GY, Chang CY, Chien JC (2005) Subdural hemorrhage in a child with acute promyelocytic leukemia presenting as subtle headache. J Chin Med Assoc 68(9):437–440. https://doi.org/10.1016/s1726-4901(09)70161-3
Locatelli F, Niemeyer CM (2015) How I treat juvenile myelomonocytic leukemia. Blood 125(7):1083–1090. https://doi.org/10.1182/blood-2014-08-550483
Locatelli F, Algeri M, Merli P, Strocchio L (2018) Novel approaches to diagnosis and treatment of Juvenile Myelomonocytic Leukemia. Expert Rev Hematol 11(2):129–143. https://doi.org/10.1080/17474086.2018.1421937
Marcu A, Colita A, Radu LE, Jercan CG, Bica AM, Asan M, Coriu D, Tanase AD, Diaconu CC, Mambet C, Botezatu A, Pasca S, Teodorescu P, Anton G, Gurban P, Colita A (2020) Single-center experience with epigenetic treatment for juvenile myelomonocytic leukemia. Front Oncol 10:484. https://doi.org/10.3389/fonc.2020.00484
Niemeyer CM, Flotho C (2019) Juvenile myelomonocytic leukemia: who's the driver at the wheel? Blood 133(10):1060–1070. https://doi.org/10.1182/blood-2018-11-844688
Niemeyer CM, Arico M, Basso G, Biondi A, Cantu Rajnoldi A, Creutzig U, Haas O, Harbott J, Hasle H, Kerndrup G, Locatelli F, Mann G, Stollmann-Gibbels B, van't Veer-Korthof E, van Wering E, Zimmermann M (1997) Chronic myelomonocytic leukemia in childhood: a retrospective analysis of 110 cases. European Working Group on Myelodysplastic Syndromes in Childhood (EWOG-MDS). Blood 89(10):3534–3543
Olk-Batz C, Poetsch AR, Nöllke P, Claus R, Zucknick M, Sandrock I, Witte T, Strahm B, Hasle H, Zecca M, Starý J, Bergstraesser E, de Moerloose B, Trebo M, van den Heuvel-Eibrink MM, Wojcik D, Locatelli F, Plass C, Niemeyer CM, Flotho C, the European Working Group of Myelodysplastic Syndromes in Childhood (EWOG-MDS) (2011) Aberrant DNA methylation characterizes juvenile myelomonocytic leukemia with poor outcome. Blood 117(18):4871–4880. https://doi.org/10.1182/blood-2010-08-298968
Palma JA, Dominguez PD, Riverol M (2013) Intracranial extramedullary hematopoiesis associated with multiple myeloma. Neurology 80(17):1620. https://doi.org/10.1212/WNL.0b013e31828f1899
Paulus S, Koronowska S, Fölster-Holst R (2017) Association between juvenile myelomonocytic leukemia, juvenile xanthogranulomas and neurofibromatosis type 1: case report and review of the literature. Pediatr Dermatol 34(2):114–118. https://doi.org/10.1111/pde.13064
Pitner SE, Johnson WW (1973) Chronic subdural hematoma in childhood acute leukemia. Cancer 32(1):185–190. https://doi.org/10.1002/1097-0142(197307)32:1<185::aid-cncr2820320128>3.0.co;2-o
Porto L, Kieslich M, Schwabe D, Zanella FE, Lanfermann H (2004) Central nervous system imaging in childhood leukaemia. Eur J Cancer 40(14):2082–2090. https://doi.org/10.1016/j.ejca.2004.04.024
Prasad BC, Chandra VV, Varaprasad G (2012) Dural metastases in chronic myeloid leukemia presenting as subdural hematoma. Turk Neurosurg 22(6):777–778. https://doi.org/10.5137/1019-5149.Jtn.4050-10.2
Sakaguchi H, Okuno Y, Muramatsu H, Yoshida K, Shiraishi Y, Takahashi M, Kon A, Sanada M, Chiba K, Tanaka H, Makishima H, Wang X, Xu Y, Doisaki S, Hama A, Nakanishi K, Takahashi Y, Yoshida N, Maciejewski JP, Miyano S, Ogawa S, Kojima S (2013) Exome sequencing identifies secondary mutations of SETBP1 and JAK3 in juvenile myelomonocytic leukemia. Nat Genet 45(8):937–941. https://doi.org/10.1038/ng.2698
Wajid MA, Gupta AK, Das G, Sahoo D, Meena JP, Seth R (2020) Outcomes of juvenile myelomonocytic leukemia patients after sequential therapy with cytarabine and 6-mercaptopurine. Pediatr Hematol Oncol 37(7):573–581. https://doi.org/10.1080/08880018.2020.1767244
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosures
None of the authors have any financial relationships to disclose.
Conflict of interest
On behalf of all authors, the corresponding author states that there is no conflict of interest.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Lambert, W.A., DiGiuseppe, J.A., Lara-Ospina, T. et al. Juvenile myelomonocytic leukemia presenting in an infant with a subdural hematoma. Childs Nerv Syst 37, 2075–2079 (2021). https://doi.org/10.1007/s00381-020-05013-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00381-020-05013-7